
Memcad 0.125mg Tablet
Marketer
Zydus Cadila
Salt Composition
Methylergometrine (0.125mg)
Overview Memcad 0.125mg Tablet
Uterine bleeding following childbirth or termination of pregnancy may be managed with a 0.125mg Memcad tablet. This medication enhances uterine smooth muscle tone, contraction frequency, and intensity, thereby minimizing blood loss. Memcad 0.125mg tablets may be ingested with or without food, but consistent timing optimizes efficacy. Dosage and frequency are determined by your physician based on your specific needs. The prescribed duration should be adhered to. Swallow the tablets whole with water. Common adverse effects include headache, elevated blood pressure, and convulsions. Report any concerning or severe side effects to your doctor; management strategies may be available. Alcohol consumption should generally be avoided during treatment. Prior to commencing treatment, inform your doctor of any pre-existing heart conditions or hypertension, and provide a complete list of all concurrently used medications, as interactions may impact Memcad's effectiveness or mechanism of action.
Uses of Memcad 0.125mg Tablet
Hemorrhage postpartum
Major Benefits of Memcad 0.125mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.125mg Memcad tablet whole; avoid crushing, chewing, or breaking it. Consumption with or without food is acceptable, though consistent timing is recommended.
Common Side effects of Memcad 0.125mg Tablet:
- High blood pressure
- Headache
- Seizure
How to use Memcad 0.125mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Memcad 0.125mg tablets can be consumed with or without food, though consistent timing is recommended.
How Memcad 0.125mg Tablet works:
Ergotamine tartrate (0.125mg) tablets, a medication derived from ergot alkaloids, induce prolonged uterine smooth muscle contractions. This constriction of blood vessels effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Memcad 0.125mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
The use of Memcad 0.125mg tablets is strongly contraindicated during pregnancy. Pregnant individuals should consult their physician; research in animals and pregnant women indicates substantial risks to fetal development.
Breast feedingCAUTION
The 0.125mg Memcad tablet requires careful consideration when breastfeeding. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Memcad 0.125mg Tablets is undetermined. Refrain from driving if concentration or reaction time is impaired.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of 0.125mg Memcad tablets in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Memcad 0.125mg Tablet use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Memcad 0.125mg Tablet :
Should you forget a Memcad 0.125mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Memcad 0.125mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Action Class | Drugs that stimulate uterine contractions and induce abortion |
